Nephros Share Price (NASDAQ: NEPH)

$3.73

▲

-0.3

(-7.44%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Nephros Stock chart to analyse performance

Nephros stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$3.72
Today's High:$3.93
$3.73
0.27%
Downside
Day's Volatility :5.22%
Upside
4.97%
52 Weeks Low:$1.36
52 Weeks High:$5.00
$3.73
63.42%
Downside
52 Weeks Volatility :72.71%
Upside
25.4%

Nephros Stock Returns

Period	Nephros Inc	Index (Russel 2000)
3 Months	19.17%	0.0%
6 Months	164.54%	0.0%
1 Year	98.93%	0.0%
3 Years	164.54%	-4.7%

Nephros Inc Key Stats

Check Nephros key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$4.03
Open	$3.925
Today's High	$3.925
Today's Low	$3.72
Market Capitalization	$42.7M
Today's Volume	$43.1K
52 Week High	$5.0
52 Week Low	$1.3643
Revenue TTM	$16.7M
EBITDA	$1.5M
Earnings Per Share (EPS)	$0.12
PE Ratio	33.58
Profit Margin	7.95%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	15.14%

Stock Returns calculator for Nephros Stock including INR - Dollar returns

The Nephros stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Nephros investment value today

Current value as on today

₹2,03,688

Returns

₹1,03,688

(+103.69%)

Returns from Nephros Stock

₹98,404 (+98.4%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Nephros Stock

400%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Nephros Stock from India on INDmoney has increased by 400% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Nephros Inc

Name
Holdings %
Name
Holdings %
Wexford Capital LP
34.04%
Topline Capital Management LLC
3.98%
Vanguard Group Inc
3.05%
Bard Associates Inc
1.24%
Geode Capital Management, LLC
0.85%
HighTower Advisors, LLC
0.53%

Analyst Recommendation on Nephros Stock

Rating

Trend

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Nephros(by analysts ranked 0 to 5 stars)

Nephros Share Price Target

What analysts predicted

Upside of 47.45%

Target:

$5.50

Current:

$3.73

Nephros share price target is $5.50, a slight Upside of 47.45% compared to current price of $3.73 as per analysts' prediction.

Nephros Stock Insights

Price Movement
In the last 7 days, NEPH stock has moved down by -10.8%
Decreasing Revenue
Revenue is down for the last 2 quarters, 4.87M → 4.41M (in $), with an average decrease of 9.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 558.0K → 237.0K (in $), with an average decrease of 57.5% per quarter

Nephros Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$10.3M	↑ 81.71%
Net Income	$-3.2M	↓ 6.55%
Net Profit Margin	-30.76%	↑ 29.06%

	FY20	Y/Y Change
Revenue	$8.6M	↓ 17.16%
Net Income	$-4.8M	↑ 49.92%
Net Profit Margin	-55.67%	↓ 24.91%

	FY21	Y/Y Change
Revenue	$10.2M	↑ 19.34%
Net Income	$-4.1M	↓ 13.83%
Net Profit Margin	-40.2%	↑ 15.47%

	FY22	Y/Y Change
Revenue	$10.0M	↓ 2.37%
Net Income	$-7.4M	↑ 79.74%
Net Profit Margin	-74.01%	↓ 33.81%

	FY23	Y/Y Change
Revenue	$14.2M	↑ 42.74%
Net Income	$-1.6M	↓ 78.66%
Net Profit Margin	-11.06%	↑ 62.95%

	FY24	Y/Y Change
Revenue	$14.2M	↓ 0.53%
Net Income	$74.0K	↓ 104.7%
Net Profit Margin	0.52%	↑ 11.58%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$3.5M	↑ 8.24%
Net Income	$-169.0K	↓ 74.16%
Net Profit Margin	-4.8%	↑ 15.3%

	Q2 FY24	Q/Q Change
Revenue	$3.3M	↓ 7.67%
Net Income	$-289.0K	↑ 71.01%
Net Profit Margin	-8.89%	↓ 4.09%

	Q3 FY24	Q/Q Change
Revenue	$3.5M	↑ 8.18%
Net Income	$183.0K	↓ 163.32%
Net Profit Margin	5.2%	↑ 14.09%

	Q4 FY24	Q/Q Change
Revenue	$3.9M	↑ 10.01%
Net Income	$349.0K	↑ 90.71%
Net Profit Margin	9.02%	↑ 3.82%

	Q1 FY25	Q/Q Change
Revenue	$4.9M	↑ 26.02%
Net Income	$558.0K	↑ 59.89%
Net Profit Margin	11.44%	↑ 2.42%

	Q2 FY25	Q/Q Change
Revenue	$4.4M	↓ 9.39%
Net Income	$237.0K	↓ 57.53%
Net Profit Margin	5.36%	↓ 6.08%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$6.1M	↑ 89.95%

	FY20	Y/Y Change
Profit	$4.9M	↓ 19.25%

	FY21	Y/Y Change
Profit	$5.6M	↑ 14.65%

	FY22	Y/Y Change
Profit	$4.7M	↓ 16.01%

	FY23	Y/Y Change
Profit	$8.4M	↑ 77.66%

	FY24	Y/Y Change
Profit	$8.7M	↑ 3.78%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$2.2M	↑ 8.21%

	Q2 FY24	Q/Q Change
Profit	$1.9M	↓ 12.57%

	Q3 FY24	Q/Q Change
Profit	$2.1M	↑ 12.4%

	Q4 FY24	Q/Q Change
Profit	$2.5M	↑ 15.17%

	Q1 FY25	Q/Q Change
Profit	$3.2M	↑ 27.43%

	Q2 FY25	Q/Q Change
Profit	$2.8M	↓ 11.38%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-2.3M	↓ 37.85%
Investing Cash Flow	$-151.0K	↓ 84.76%
Financing Cash Flow	$2.0M	↓ 71.38%

	FY20	Y/Y Change
Operating Cash Flow	$-6.9M	↑ 203.3%
Investing Cash Flow	$-239.0K	↑ 58.28%
Financing Cash Flow	$11.2M	↑ 456.07%

	FY21	Y/Y Change
Operating Cash Flow	$-1.4M	↓ 79.47%
Investing Cash Flow	$-85.0K	↓ 64.44%
Financing Cash Flow	$237.0K	↓ 97.89%

	FY22	Y/Y Change
Operating Cash Flow	$-3.2M	↑ 128.23%
Investing Cash Flow	$-137.0K	↑ 61.18%
Financing Cash Flow	$34.0K	↓ 85.65%

	FY23	Y/Y Change
Operating Cash Flow	$827.0K	↓ 125.57%
Investing Cash Flow	$-75.0K	↓ 45.26%
Financing Cash Flow	$-79.0K	↓ 332.35%

	FY24	Y/Y Change
Operating Cash Flow	$-492.0K	↓ 159.49%
Investing Cash Flow	$-50.0K	↓ 33.33%
Financing Cash Flow	$-5.0K	↓ 93.67%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-501.0K	↓ 25.45%
Investing Cash Flow	$-50.0K	-
Financing Cash Flow	$-2.0K	↑ 0.0%

Nephros Technicals Summary

Sell

Neutral

Buy

Nephros is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Nephros Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Nephros Inc	9.06%	164.54%	98.93%	164.54%	-47.17%
Intuitive Surgical, Inc.	-2.14%	-16.61%	-2.2%	129.39%	91.27%
Alcon Ag	-9.17%	-15.22%	-16.6%	20.12%	40.07%
West Pharmaceutical Services Inc	3.24%	8.32%	-18.78%	-16.58%	-12.33%
Resmed Inc.	-1.56%	17.91%	12.23%	25.22%	53.62%
Becton, Dickinson And Company	9.36%	-15.57%	-20.36%	-24.43%	-19.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Nephros Inc	33.58	33.58	0.0	0.05	0.15	0.07	NA	0.91
Intuitive Surgical, Inc.	66.27	66.27	3.47	8.14	0.16	0.09	NA	49.79
Alcon Ag	36.78	36.78	2.16	3.1	0.05	0.03	0.0	44.73
West Pharmaceutical Services Inc	36.74	36.74	3.55	6.76	0.18	0.11	0.0	40.74
Resmed Inc.	28.99	28.99	1.9	9.5	0.26	0.14	0.01	40.77
Becton, Dickinson And Company	35.34	35.34	0.96	14.37	0.06	0.04	0.02	88.87

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Nephros Inc	Buy	$42.7M	-47.17%	33.58	7.95%
Intuitive Surgical, Inc.	Buy	$169.9B	91.27%	66.27	28.51%
Alcon Ag	Buy	$39.3B	40.07%	36.78	10.7%
West Pharmaceutical Services Inc	Buy	$17.7B	-12.33%	36.74	16.48%
Resmed Inc.	Buy	$40.3B	53.62%	28.99	27.22%
Becton, Dickinson And Company	Buy	$55.3B	-19.91%	35.34	7.41%

About Nephros Inc

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, bacteria, cysts, particulates, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Organization	Nephros
Employees	31
CEO	Mr. Robert Banks
Industry	Medical Specialties

Key Management of Nephros Inc

Name	Title
Mr. Robert Banks	President, CEO & Director
Ms. Judy F. Krandel C.F.A.	Chief Financial Officer
Brianne McGuire	Director of Brand, Marketing & Business Development
Vashone R. Thomas	Vice President of Quality, Regulatory, & Human Resources
Mr. Greg Lucas	President of Aether Water Systems
Ms. Judy Mazzini	Controller

Important FAQs about investing in NEPH Stock from India :

What is Nephros share price today?

Nephros share price today is $3.73 as on August 30, 2025 at 1:29 am IST at the close of the market. Nephros share today touched a day high of $3.93 and a low of $3.72.

What is the 52 week high and 52 week low for Nephros share?

Nephros share touched a 52 week high of $5.00 and a 52 week low of $1.36. Nephros stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $3.73, lower by 25.4% versus the 52 week high.

How to invest in Nephros Stock (NEPH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nephros on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nephros Shares that will get you 0.4021 shares as per Nephros share price of $3.73 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Nephros Stock (NEPH) from India?

Indian investors can start investing in Nephros (NEPH) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Nephros stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Nephros share’s latest price of $3.73 as on August 30, 2025 at 1:29 am IST, you will get 2.6810 shares of Nephros. Learn more about fractional shares .

What are the returns that Nephros has given to Indian investors in the last 5 years?

Nephros stock has given -47.17% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?